Quarterly ResultMay 5, 2026, 04:13 PM
MedWellAI Q3 Revenue $618.7K, Net Loss $(240.2K); Liabilities Rise
AI Summary
MedWellAI reported a significant increase in total revenue for the three months ended March 31, 2026, reaching $618,676, primarily driven by new product sales. The company's net loss attributable to shareholders improved to $(240,237) from $(588,630) in the prior year. However, total liabilities surged to $7.78 million, largely due to the reclassification of Series C convertible preferred stock, and cash balances decreased. The company continues its focus on AI-driven healthcare and wellness solutions.
Key Highlights
- Total revenue for the three months ended March 31, 2026, increased to $618,676 from $281,318 year-over-year.
- Net loss attributable to MedWellAI, Inc. improved to $(240,237) in Q3 2026 from $(588,630) year-over-year.
- Product sales, net, generated $596,176 in Q3 2026, a new revenue stream compared to $0 year-over-year.
- Total liabilities increased to $7,845,767 as of March 31, 2026, from $3,140,935 as of June 30, 2025.
- Cash decreased to $130,028 as of March 31, 2026, from $401,310 as of June 30, 2025.
- Series C convertible preferred stock of $6,500,000 was classified as a current liability.
- Nine-month revenue increased to $1,694,482 from $425,327 year-over-year.
- Nine-month net loss improved to $(1,179,634) from $(2,478,588) year-over-year.